PTCA Coronary Drug Eluting Balloons Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL PTCA CORONARY DRUG ELUTING BALLOONS INDUSTRY

2.1 Summary about PTCA Coronary Drug Eluting Balloons Industry

2.2 PTCA Coronary Drug Eluting Balloons Market Trends

2.2.1 PTCA Coronary Drug Eluting Balloons Production & Consumption Trends

2.2.2 PTCA Coronary Drug Eluting Balloons Demand Structure Trends

2.3 PTCA Coronary Drug Eluting Balloons Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 DEB Balloon

4.2.2 Standard Balloon

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Small Vessel Disease

4.3.2 Bifurcation Lesions

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 DEB Balloon

5.2.2 Standard Balloon

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Small Vessel Disease

5.3.2 Bifurcation Lesions

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 DEB Balloon

6.2.2 Standard Balloon

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Small Vessel Disease

6.3.2 Bifurcation Lesions

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 DEB Balloon

7.2.2 Standard Balloon

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Small Vessel Disease

7.3.2 Bifurcation Lesions

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 DEB Balloon

8.2.2 Standard Balloon

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Small Vessel Disease

8.3.2 Bifurcation Lesions

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 DEB Balloon

9.2.2 Standard Balloon

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Small Vessel Disease

9.3.2 Bifurcation Lesions

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 B.Braun

10.1.2 Spectranetics

10.1.3 Concept Medical

10.1.4 Eurocor

10.1.5 Lifetech

10.1.6 Maxcor

10.1.7 Micell

10.1.8 Qualimed

10.1.9 Acrostak

10.2 PTCA Coronary Drug Eluting Balloons Sales Date of Major Players (2017-2020e)

10.2.1 B.Braun

10.2.2 Spectranetics

10.2.3 Concept Medical

10.2.4 Eurocor

10.2.5 Lifetech

10.2.6 Maxcor

10.2.7 Micell

10.2.8 Qualimed

10.2.9 Acrostak

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table PTCA Coronary Drug Eluting Balloons Product Type Overview

Table PTCA Coronary Drug Eluting Balloons Product Type Market Share List

Table PTCA Coronary Drug Eluting Balloons Product Type of Major Players

Table Brief Introduction of B.Braun

Table Brief Introduction of Spectranetics

Table Brief Introduction of Concept Medical

Table Brief Introduction of Eurocor

Table Brief Introduction of Lifetech

Table Brief Introduction of Maxcor

Table Brief Introduction of Micell

Table Brief Introduction of Qualimed

Table Brief Introduction of Acrostak

Table Products & Services of B.Braun

Table Products & Services of Spectranetics

Table Products & Services of Concept Medical

Table Products & Services of Eurocor

Table Products & Services of Lifetech

Table Products & Services of Maxcor

Table Products & Services of Micell

Table Products & Services of Qualimed

Table Products & Services of Acrostak

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global PTCA Coronary Drug Eluting Balloons Market Forecast (Million USD) by Region 2021f-2026f

Table Global PTCA Coronary Drug Eluting Balloons Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global PTCA Coronary Drug Eluting Balloons Market Forecast (Million USD) by Demand 2021f-2026f

Table Global PTCA Coronary Drug Eluting Balloons Market Forecast (Million USD) Share by Demand 2021f-2026f